Document is current
Any future updates will be listed below
-
Authors
Jonsson, Vanessa D.
Blakely, Collin M.
Lin, Luping
Asthana, Saurabh
Matni, Nikolai
Olivas, Victor
Pazarentzos, Evangelos
Gubens, Matthew A.
Bastian, Boris C.
Taylor, Barry S.
Doyle, John C.
Bivona, Trever G.
- License Information
-
More Information
Article History
Received: 23 November 2016
Accepted: 6 February 2017
First Online: 13 March 2017
Competing interests
: T.G.B. is a consultant to Astrazeneca, Novartis, Array, Revolution Medicines and has received research funding from Ignyta. C.M.B. has received funding from Clovis Oncology, Ignyta, and MedImmune.
